The number of people with susceptibility test result for rifampicin in Congo, Democratic Republic of the
Congo, Democratic Republic of the: The number of people with susceptibility test result for rifampicin was 28,577 in 2021. ◆ Volatile
Latest (2021)
28,577
Change on year
up 153.5%
World rank
10th
of 155 countries
All-time high
28,577
in 2021
All-time low
2,494
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Congo, Democratic Republic of the, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Congo, Democratic Republic of the recorded 28,577 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 153.5% on the previous year and up 510.4% over five years.
That places Congo, Democratic Republic of the 10th out of 155 countries with data for 2021, putting it in the top 10%.
The number of people with susceptibility test result for rifampicin in Congo, Democratic Republic of the, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 4,682 | — |
| 2018 | 2,494 | -46.7% |
| 2019 | 7,189 | +188.3% |
| 2020 | 11,274 | +56.8% |
| 2021 | 28,577 | +153.5% |
Congo, Democratic Republic of the compared with similar countries
- Congo, Democratic Republic of the's 28,577 is above the median for low income countries, which is 1,934, 14.8× the median. (15 countries reporting)
- Congo, Democratic Republic of the's 28,577 is above the median for Sub-Saharan Africa, which is 2,015, 14.2× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 4,788 | 2,494 | 7,189 | 3 |
| 2020s | 19,926 | 11,274 | 28,577 | 2 |
Countries ranked near Congo, Democratic Republic of the
More health data for Congo, Democratic Republic of the
- Un projection of annual infant deaths, annual growth rate -1.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 821.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133,650 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 390 (2025)
- Population ages 00-04, female, annual growth rate 2.56 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0895 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.59 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Congo, Democratic Republic of the?
- The number of people with susceptibility test result for rifampicin in Congo, Democratic Republic of the was 28,577 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Congo, Democratic Republic of the?
- The highest recorded value was 28,577 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Congo, Democratic Republic of the?
- The lowest recorded value was 2,494 in 2018.
- How does Congo, Democratic Republic of the rank for the number of people with susceptibility test result for rifampicin?
- Congo, Democratic Republic of the ranks 10th out of 155 countries with data for 2021.
- Where does this Congo, Democratic Republic of the data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).